ERK inhibits osteoclast differentiation in RAW 264.7 cells through the osteoprotegerin-mediated autophagy

Soo-Young Shin1, In-Soon Kang2, Chaekyun Kim1

  • 1Laboratory of Leukocyte Signaling Research, Department of Pharmacology, College of Medicine, Inha University, Incheon 22212, Republic of Korea; BK21, Program in Biomedical Science and Engineering, Inha University, Incheon 22212, Republic of Korea.

Bone
|February 13, 2025
PubMed

Insights

Extracellular signal-regulated kinase (ERK) pathway impacts osteoclast (OC) differentiation differently in various cells. In RAW 264.7 cells, ERK inhibition promotes OC differentiation by reducing osteoprotegerin and autophagy.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Bone Biology

Background:

  • Osteoclasts (OCs) are crucial for bone resorption, originating from monocytes/macrophages.
  • The extracellular signal-regulated kinase (ERK) pathway influences cell proliferation, differentiation, and survival, including OCs.
  • ERK's precise role in OC differentiation requires further elucidation due to cell-type-specific effects.

Purpose of the Study:

  • To investigate the differential effects of ERK inhibition on OC differentiation in bone marrow-derived macrophages (BMMs) and RAW 264.7 cells.
  • To elucidate the underlying molecular mechanisms by which ERK regulates OC differentiation in RAW 264.7 cells.
  • To explore the interplay between ERK, osteoprotegerin (OPG), and autophagy in OC differentiation.

Main Methods:

  • Treatment of BMMs and RAW 264.7 cells with ERK inhibitors.
  • ERK downregulation using small interfering RNA (siRNA) in RAW 264.7 cells.
  • Analysis of OC-specific markers, transcription factors, OPG expression, and autophagy-related proteins (LC3-II, p62).
  • Investigation of the Akt/mammalian target of the rapamycin (mTOR) and unc-51-like autophagy activating kinase 1 (ULK1) signaling pathways.

Main Results:

  • ERK inhibitors reduced BMM proliferation but decreased OC differentiation in BMMs while increasing it in RAW 264.7 cells.
  • ERK downregulation in RAW 264.7 cells enhanced OC differentiation and expression of key OC markers.
  • ERK inhibition in RAW 264.7 cells decreased OPG expression and autophagy (via Akt/mTOR activation and ULK1 inhibition), promoting OC formation.
  • OPG knockdown mimicked the effects of ERK inhibition on autophagy.

Conclusions:

  • ERK plays a complex, cell-dependent role in regulating OC differentiation.
  • In RAW 264.7 cells, ERK negatively regulates OC differentiation by suppressing OPG expression and autophagy.
  • Targeting the ERK pathway may offer novel therapeutic strategies for bone disorders characterized by aberrant OC activity.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.0K